HomeInsightsMarket Capitalization

Market Capitalization of Bal Pharma Ltd

Market Capitalization of Bal Pharma Ltd

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

2.6 K

stocks traded

Last Updated time: 16 Sep 15:30 PM

Image

Bal Pharma Ltd

NSE: BALPHARMA

MARKETCAP

217.31 crore

Last updated: 13 Sep 24

Key Highlights

  • The Market Cap of Bal Pharma Ltd is ₹ 217.31 crore as of 13 Sep 24.
  • The Market Cap of Bal Pharma Ltd changed from ₹ 99.92 crore on March 2019 to ₹ 144.21 crore on March 2024 . This represents a CAGR of 6.31% over 6 years. .
  • The Latest Trading Price of Bal Pharma Ltd is ₹ 135.3 as of 16 Sep 15:40.

Historical Market Cap of Bal Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Bal Pharma Ltd

No data available

Image

Bal Pharma Ltd

NSE: BALPHARMA

PRICE

135.3

-2.20 (-1.60%)

stock direction

Last updated: 16 Sep 15:40

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Bal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

SWOT Analysis Of Bal Pharma Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bal Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Bal Pharma Ltd28217
Sun Pharmaceuticals Industries Ltd424,44,825
Divis Laboratories Ltd871,45,892
Cipla Ltd301,33,994
Torrent Pharmaceuticals Ltd691,16,950
Zydus Lifesciences Ltd271,12,547

Key Valuation Metric of Bal Pharma Ltd

No data available

Historical P/E Ratio of Bal Pharma Ltd

No data available

* All values are in %

Historical Revenue of Bal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bal Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Bal Pharma Ltd

No data available

* All values are in %

About Bal Pharma Ltd

  • Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87.
  • In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations.
  • BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc.
  • The company promotes its products through the common sales force of the group but proposes to induct its own soon.
  • It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.

Bal Pharma Ltd News Hub

News

Bal Pharma to convene board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 9 September 202...

Read more

31 Aug 202410:27

News

Bal Pharma schedules AGM

Bal Pharma announced that the Annual General Meeting (AGM) of the company will be held on ...

Read more

16 Aug 202411:19

News

Bal Pharma schedules board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2024....

Read more

26 Jul 202416:28

News

Board of Bal Pharma recommends final dividend

Bal Pharma announced that the Board of Directors of the Company at its meeting held on 28 ...

Read more

29 May 202409:43

News

Bal Pharma Ltd leads gainers in 'B' group

Amines & Plasticizers Ltd, Jet Freight Logistics Ltd, Arrow Greentech Ltd and Emkay Global...

Read more

29 May 202412:15

News

Bal Pharma hits the roof after Q4 PAT surges to Rs 5 cr

Revenue from operations jumped 14.76% YoY to Rs 94.62 crore in Q4 FY24. Profit before tax ...

Read more

29 May 202414:47

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Bal Pharma Ltd

What is the market cap of Bal Pharma Ltd?

As of September 16, 2024, Bal Pharma Ltd has a market capitalization of ₹217.31, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Bal Pharma Ltd's market capitalization?

Bal Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Bal Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Bal Pharma Ltd's market capitalization change?

Bal Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*